Summary Tumour necrosis factor (TNF)-a induces apoptosis in a human acute myeloid leukaemia cell line, Kasumi-l. To examine the role of protein phosphorylation in signal transduction of TNF-a-induced apoptosis, a variant cell line resistant to TNF-a was established by an intermittent challenge of Kasumi-l cells with increasing concentrations of TNF-a for 6 months. The mechanism of resistance to TNF-a appears to be in the post-receptor pathway because expression of p55 TNF receptor in the variant cells is increased compared with that of the parental Kasumi-I cells. In renaturation assays, TNF-a induced a rapid activation of different protein kinases of different molecular weights, including the 50 kDa protein kinase (PK50) followed by the 35 kDa protein kinase (PK35), in the parental Kasumi-I cells. The dose-response of TNF-a required to activate PK50 and PK35 was closely related to concentrations of TNF-a that induced apoptosis. Treatment of Kasumi-1 cells with ceramide also activated PK35. In TNF-resistant variant cells, activation of PK35 in response to TNF-a or ceramide was practically nil. These findings suggest that activation of PK35 through the ceramide pathway may play an important role in signal transduction of TNF-a in the Kasumi-I cell line, while the decreased activation of PK35 may explain the insensitivity of the variant cells towards TNF-a.
Tumour necrosis factor (TNF)-a exerts multiple biological activities in various cell systems, including inhibition of cell growth, cytocidal activity and modulation of gene transcription (Old, 1985; Beutler and Cerami, 1989; Vilcek and Lee, 1991) . Two distinct TNF receptors of 75 kDa (P75 receptor) (Smith et al., 1990) and 55 kDa (P55 receptor) (Loetscher et al., 1990; Schall et al., 1990) have been identified. The P55 receptor was found to transmit cytotoxic effects of TNF (Tartaglia et al., 1993) . The 45 amino acids of the intracellular domain of the P55 receptor (332-376) have 51% homology to the corresponding domain of the human Fas antigen (230-274) (Itoh et al., 1991) . Mutant proteins of the P55 TNF receptor in which most of the intracellular domain has been removed are defective in initiating cytotoxicity, hence the importance of this domain in mediating TNF signalling (Tartaglia et al., 1993) . The intracellular domain of the P55 receptor and that of the P75 receptor do not have a kinase domain (Loetscher et al., 1990; Schall et al., 1990) , and little is known of the molecular mechanism responsible for the multiple biological activities of TNF.
A novel signal transduction pathway involved in mediating some effects of TNF has been identified (Kim et al., 1991; Kolesnick and Golde, 1994) . This pathway, referred to as the sphingomyelinase pathway, is initiated by activation of neutral sphingomyelinase, which hydrolyses membrane sphingomyelin to ceramide. Ceramide acts as a second messenger molecule and can stimulate a membrane-bound serine/threonine kinase, termed 97 kDa ceramide-activated protein kinase (Liu et al., 1994) . However, precise mechanisms leading to activation of sphingomyelinase and downstream events after ceramideactivated protein kinase remain unclear.
We report here that the human myeloid leukaemia cell line, Kasumi-l (Asou et al., 1991) TNF-a (1 U ml-') was added to the culture of 3 x 107 Kasumi-1 cells and incubated for 1 week. When cell viability decreased to < 5%, cells were resuspended in medium without TNF-a and allowed to grow for several days before TNF-a was re-added. Intermittent exposure to increasing concentrations of TNF-a was maintained for 6 months until cultures could be kept in 1000 U ml-' TNF-a. When TNF-a was removed from the selective medium for as long as 6 months, re-exposure to TNF-oe did not lead to cell death. The TNF-resistant Kasumi-1 cell line still possessed t(8;21) chromosomal abnormality (data not shown).
Assessment of cell growth
The growth-inhibitory effects were assessed by plating cells in 96-multiwell dishes (Nunc 167008) at a final density of 5-7 x 105 cells ml-'. Cells were incubated with or without various concentrations of TNF-cx for indicated times, then the proliferation was measured by incubating cells with 0.5 mM WST-l and 0.02 mM 1-methoxy PMS for 2 h, and the absorbance was measured at 605 nm, as described (Ishiyama et al., 1993) .
Analysis of the expression of TNF receptor Parental and variant Kasumi-I cells were analysed for expressions of P55 and P75 TNF receptors by indirect immunofluorescence with monoclonal antibodies against P55 and P75 TNF receptors. Fluorescence was evaluated on FACScan flow cytometer, as described previously (Washio et al., 1992) .
Preparation of cell extract Cells at logarithmic growth phase were incubated with or without various concentrations of TNF-a at 37°C for indicated times, and washed once with ice-cold phosphatebuffered saline (PBS). All subsequent steps were carried out at 4°C. The cells were resuspended in lysis buffer (20 mM Tris-HCl, pH 7.5, 5 mM EGTA, 50 mM 2-glycerophosphate, 6 mM dithiothreitol, 0.5% Triton X-100, 0.1 mm sodium fluoride, 1 mM sodium vanadate, 1 ,ug ml-' leupeptin, 2 mM phenylmethylsulphonyl fluoride) to a concentration of 2.5 x 107 cells ml-' for 30 min and then centrifuged at 4000 g for 10 min. The supernatant served as the cell extract. Protein concentration was determined using the Bio-Rad protein assay system (Tokyo, Japan).
In vitro renaturation assay of protein kinase using polyacrylamide gels containing MBP Cell lysates were prepared as described above and were used as the enzyme solution. Various kinase activities were examined in gel renaturation assays essentially as described by Kameshita and Fujisawa (1989) , with a minor modification. MBP (0.5 mg ml-') was added to the separating gel solution just before polymerisation, as a substrate protein.
After electrophoresis, the gel was washed twice with 50 mM Tris-HCl (pH 8.0), 20% 2-propanol to remove sodium dodecyl sulphate (SDS) and twice with buffer A (50 mM Tris-HCl (pH 8.0), 5 mM 2-mercaptoethanol), each wash for 30 min at room temperature. To denature proteins the gel was treated twice with 6 M guanidine in buffer A with each treatment for 30 min at room temperature. Enzymes in the guanidine-treated gel were allowed to renature in 0.04% Tween 40 in buffer A at 4°C for 16 h with several changes of solution. After renaturation, the gel was preincubated in buffer B (40 mM Tris-HCl (pH 8.0), 50 mm sodium chloride, 20 mm potassium chloride, 10 mm magnesium chloride, 0.1 mM EGTA, and 2 mM dithiothreitol) for 30 min at room temperature. Phosphorylation was carried out by incubating the gel with buffer B containing 20,M [y-32P]ATP (10 4uCi ml-') for 60 min at 25°C. After incubation, the gel was washed thoroughly with 5% trichloroacetic acid and 1% sodium pyrophosphate, dried, then either processed for autoradiography or analysed using a Fujix BAS2000 Bio-imaging analyser.
Phosphoamino acid analysis
Bands corresponding to PK50 and PK35 were excised from dried gel after renaturation assay as described (Cooper et al., 1983) . The protein in the gel slice was digested with N-TNF-cx activates multple serine/threonine protein kinases M Ido et a! 361 tosylphenylalanyl chloromethyl ketone-treated type XIII trypsin (1 mg ml-') and hydrolysed in 6 N hydrochloric acid at 110°C for 1 h. The samples were lyophilised, dissolved in water and electrophoresed on cellulose thinlayer plate (Merck 5715) at pH 3.5 (5% acetic acid, 0.5% pyridine) at 500 V for 60 min in the presence of authentic standards of phosphoserine, phosphothreonine and phosphotyrosine. Standards were detected by ninhydrin staining and radiolabelled amino acids were detected by autoradiography.
Immunoprecipitation of MAP kinase The parental and the variant Kasumi-1 cells (5 x 106 cells) were treated with either TNF-a (1000 U ml-') or GM-CSF (1000 U ml-') for 15 min and washed with ice-cold PBS. Immunoprecipitation of MAP kinase was done as described by Gotoh et al. (1991) . Immune complexes were then collected on anti-mouse IgG-conjugated Sepharose beads for 60 min, washed four times with lysis buffer and eluted with SDS-PAGE sample buffer. Immunoprecipitated proteins were either analysed with Western blotting using anti-MAP kinase or in vitro renaturation kinase assay using MBP as a substrate protein, as described above.
Results

Cell growth
The effects of TNF-a on the proliferation of parental and variant Kasumi-1 cells were examined. As shown in Figure 1 , TNF-ac dose-dependently inhibited the growth of parental cells, whereas the variant cells were completely resistant to TNF-a at concentrations as high as 1000 U ml-'. There was a significant difference in the sensitivity of these cell lines to TNF-a over 1 U ml-l at P <0.05. Cytological studies under light microscopy revealed that TNF-a-treated parental cells exhibited morphological features consistent with apoptosis, including marked condensation and fragmentation of nuclei, whereas untreated parental cells and both treated and untreated variant cells rarely exhibited apoptosis (data not shown).
Expression of P55 and P75 TNF receptors To determine the molecular mechanism of resistance to TNFa in variant cells, the expression of P55 and P75 TNF receptors in both cell lines was examined. (Figure 4 ). The dose dependency of TNF-x for the activation of PK50 and PK35 seems to be closely related to that for the induction of growth inhibition in the parental cells (Figures 1  and 5 ). To determine the statistical validity of these data, we performed several additional experiments and analysed the data obtained with Student's t-test. Since the absolute radioactivity of PK35 and PK50 varies from one experiment to another, we evaluated the relative increase in these kinase activities by dividing the radioactivity of PK35 and PK50 at 60 min after TNF-a stimulation with those at 0 min respectively. As shown in Table I , TNF-a induced an increase in PK35 and PK50 activity in the parental Kasumi-1 cell line. However, no increase in these kinase activities could be seen in the TNF-resistant cell line. There is a significant difference in the activation of these kinase levels between the parental and the TNF-resistant cell lines.
From their similarity in molecular weight and their ability to phosphorylate MBP, it was suspected that one of these kinases (PK50 or PK35) would be MAP kinase. To address this question, cell extracts from parental and variant cells, treated with or without TNF-ax or GM-CSF for 15 min, were evaluated for MAP kinase by immunoprecipitation with anti-MAP kinase and renaturation kinase assay. As shown in parental Kasumi-l cells, whereas GM-CSF activated MAP kinase in both cell lines. Thus, TNF-a-activated kinases, including PK50 and PK35, are different from MAP kinase.
Discussion
The human acute myeloid leukaemia cell line, Kasumi-1, is very sensitive to TNF-oa-induced cell death (IC50=4.33 U ml-). Light microscopy and DNA fragmentation studies revealed that TNF-a induces cell death through apoptosis rather than through necrosis (data not shown). To better understand the molecular mechanisms of TNF-ac on Kasumi-1 cells, we selected variant cells resistant to TNF-a by intermittent challenge of TNF-c for 6 months. Even when these cells were grown in the absence of TNF-a for more than 6 months, re-exposing them to TNF-a did not induce apoptosis, even at concentrations as high as 1000 U ml-'.
We asked if the down-regulation of TNF receptor was responsible for the insensitivity of the variant cells. We found that the expression of both P55 and P75 TNF receptors is increased, hence, mechanisms related to resistance of the variant cells to TNF-ai (Kyriakis et al., 1994) . In the present study, we examined the effect of TNF-a on activation of protein kinases, using renaturation assays. In the parental Kasumi-1 cells, TNF-a stimulated serine/threonine kinases including PK50 and PK35, which are different from MAP kinase. SAPK is a proline-directed serine/threonine kinase and belongs to the family of MAP kinase. SAPK was found to be activated by stressful stimuli including treatment of cells with TNF, cytotoxic drugs or heat shock (Kyriakis et al., 1994) . Although PK50 and PK35 were not identified, the similarity in molecular weight and the ability of these kinases to phosphorylate MBP suggest that one of them may be related to SAPK and further studies to determine this are ongoing. Some TNF actions are considered to be transmitted through the activation of sphingomyelinase and the subsequent generation of ceramide (Kolesnick and Golde, 1994) . We also examined the effect of ceramide on the growth and the activation of these kinases. Treatment of parental Kasumi-1 cells with ceramide resulted in growth inhibition (data not shown) and in activation of PK35 (Figure 3) . However, PK50 could not be activated by ceramide. Therefore, PK50 is either upstream of sphingomyelinase or resides in a different signalling pathway. The variant cells showed resistance to the growth-inhibitory effect of ceramide (data not shown). In addition, PK35 could not be activated when the variant cells were treated with TNF-oa or ceramide.
Therefore, TNF-a may transmit signals through the sphingomyelinase pathway and may induce PK35 activation, which would result in an apoptosis in Kasumi-I cells.
Ceramide is reported to activate 97 kDa serine/threonine kinase, termed ceramide-activated protein kinase (Kolesnick and Golde, 1994) . In the present study, we found that treatment of parental cells with TNF-a or ceramide resulted in activation of PK35 (Figure 3 ). PK35 and ceramideactivated protein kinase can use MBP as an in vitro substrate. Liu et al. (1994) reported that treatment of HL-60 cells with TNF resulted in activation of ceramide-activated protein kinase between 5 and 10 min. In the present study, we noted that PK35 is activated around 60 min after TNF treatment. Hence, in size and kinetics of activation, PK35 may differ from ceramide-activated protein kinase.
In conclusion, TNF-a stimulates several serine/threonine kinases including PK50 and PK35 in parental Kasumi-1 cells. PK35 may prove to be a new member of the ceramideactivated protein kinase family and the lack of the activation of PK35 may be related to insensitivity of the variant cells to TNF-cc.
